11th ESPID Research Masterclass
Keynote Lecture – Nicole Ritz and Paul Heath
The ESPID Research Masterclass (ERMC) is a closed, seminar type of forum for active paediatric infectious diseases (PID) research groups in Europe. ERMC 2019 will take place at the Intercontinental Hotel in Emona I room. The research performed can involve ‘bench-type’ basic and translational research, as well as ‘bed-side’ clinical studies and epidemiological studies in any area of paediatric infectious diseases. Please see detailed programme below.
The primary aim of ERMC is to provide better opportunities for young researchers to present their studies and discuss their research with other junior colleagues as well as with European research group leaders.
The second aim of the seminar is to provide the researchers a better view of recent PID research in Europe and also to stimulate discussions of new research collaborations among ESPID members.
The ERMC is based on attendance of research teams. The research groups should apply their attendance as a group of one (1) senior and maximum three (3) junior researchers (maximum group size is four (4) persons). The senior researcher in the group should be an ESPID member.
The 11th ESPID Research Masterclass will take place in Ljubljana, Slovenia on Saturday, May 11, 2019 from 08:30-18:30
Intercontinental Hotel in Emona I room
ERMC 2019 Programme
9.00-9.20 Welcome and introduction
Theo Zaoutis (USA)
9.20-9.40 The role of the ERMC in our research group.
9.40-10.05 Establishment Of Serotype-Specific Immunological Memory By Different Infant Immunization Schedules With PCV13
10.05-10.30 Are Patients With Atypical-Hemolytic Uremic Syndrome, Treated With Eculizumab, Protected Against Neisseria Meningitidis With 4c-Menb Vaccination?
10.30-10.55 Pneumonia In Children With Sickle-Cell Disease In The PCV10 Era: What Has Changed?
10.55-11.25 Coffee Break
Workshop: Nicole Ritz (Switzerland) -: How to manage a research project: skills and pitfalls
11.25-12.00 Session II: TBC
12.00-12.20 Antibiotic Prescribing In Pediatric Outpatients In Greece, 2015-2018
12.20-12.40 Interventions To Reduce Antimicrobial Resistance: Antibiotic Stewardship, Infection Control, And Molecular Diagnostics In Critically Ill Children
12.40-13.00 Intensification Of A Paediatric Antimicrobial Stewardship Program In Spain: Experience After 18 Months.
13.45-14.45 Keynote lecture
Professor Paul Heath (UK)
Building collaborations: from small to large
14.45-15.10 Not All UTIs Are The Same: Towards An Individualized Management Of Utis In Children
15.10-15.35 Complicated Forms Of UTI In Children: Setting The Index Of Suspicion
15.35-16.00 Coffee Break
16.00-16.25 Surviving And Thriving? Outcomes Of HIV-Exposed Children In Rural Zimbabwe
16.25-16.50 Systemic Cytokines And Chemokines Associated With Radiographical Abnormalities In Community-Acquired Pneumonia Among Children
16.50-17.15 The T-Cell Activation Marker For TB (TAM-TB): A New Diagnostic Tool For Paediatric TB
17.15-18.05 Clinical Presentations And Aetiologies Of Fever Of Children In Nepal
18.05-18.30 Closing remarks and Awards
All applications were sent to the ESPID Administrator email@example.com by 18 January 2019, in order to be considered.
ERMC Organising Committee
*If you have submitted an application to participate in the Masterclass, please do not register to the Meeting until notification of acceptance to the Masterclass has been sent to you.
Each junior from every group will receive EUR 350 from ESPID which will be paid after the meeting in Ljubljana. This amount should support travel costs and the cost of an overnight stay at the Intercontinental Hotel in Ljubljana – Emona I Room. In addition, ESPID will waive the annual meeting registration fee for all junior participants, providing that they are ESPID members. Senior members are expected to cover the costs of their attendance from their own budget.
APPLICATION PERIOD CLOSED
HOW TO APPLY:
All applications must include the following:
· A short summary (max. one page, A4) of current research interests of the group
· A list of 10 recent publications from the group
· A brief CV (max 2 pages) from each junior member including current position, degrees, publications, presentations at (inter)national meetings, and number of years spend on research
· Abstracts* from individual junior members
· A list of the participants (1 senior, max. 3 juniors) with their e-mail addresses
· A one slide power point presentation of the team
* The abstract should not exceed 250 words in total and must be structured into separate sections. The format of ERMC is well suited to present work-in-progress resulting in getting valuable feedback and input from other research groups how to approach the research question, as well as discussing the study design with senior research leaders in paediatric infectious diseases and obtain their expert opinion.
The following format for the individual abstract should be used:
· Title not exceeding 16 words
· Authors and affiliations
· Research question including context and purpose of the study
· Methods including rational why a particular method was chosen to answer the research question
· Results can be ranging from work in progress, to preliminary data, to more conclusive results
· Conclusion including problems encountered, adjustment of methods and work plan for the next year.
Please note that 1-2 of junior members from each team should be ready to give an oral presentation of their research.
Deadline of submission is January 18, 2019. All applications are to be sent to the ESPID Administrator firstname.lastname@example.org
What happens then: Based on the interest of the European PID research groups applying to participate, the ERMC organising committee will make the final decision about the topics of the day including the abstracts selected for oral presentation. All research groups will be directly informed about the selected topics, abstracts and groups before February 18, 2019.